Retatrutide 

Acts on three hormone receptors GLP-1, GIP, and glucagon, which is why it is often called a triple agonist. It works by activating three receptors:

• GLP-1 receptor – helps reduce appetite and slow stomach emptying.

• GIP receptor – may improve insulin response and metabolic effects.

• Glucagon receptor – may increase energy expenditure and fat burning.

Potential effects seen in clinical research include:

• Significant weight loss

• Reduced appetite

• Improved blood sugar control

• Possible improvements in metabolic markers

Research Use Only. Not for human consumption, diagnosis, treatment, or prevention of any disease